DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹9,986 Cr | ₹9,571 Cr | ₹9,439 Cr | ₹8,634 Cr | ₹8,356 Cr |
What is the latest Total Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹9,986 Cr |
| Mar2024 | ₹9,571 Cr |
| Mar2023 | ₹9,439 Cr |
| Mar2022 | ₹8,634 Cr |
| Mar2021 | ₹8,356 Cr |
How is Total Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,986 Cr | 4.34 | |
| Mar2024 | ₹9,571 Cr | 1.39 | |
| Mar2023 | ₹9,439 Cr | 9.33 | |
| Mar2022 | ₹8,634 Cr | 3.33 | |
| Mar2021 | ₹8,356 Cr | - | |
Compare Total Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹3,804.8 Cr | 20.6% | 6.7% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 20.6% |
6.7% |
-17.5% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses